- Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy
- Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders
- Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights
- Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
- Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
More ▼
Key statistics
As of last trade Satellos Bioscience Inc (MSCLF:QBB) traded at 0.4139, -27.40% below its 52-week high of 0.5701, set on Feb 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4229 |
---|---|
High | 0.4229 |
Low | 0.4139 |
Bid | -- |
Offer | -- |
Previous close | 0.4139 |
Average volume | 5.45k |
---|---|
Shares outstanding | 112.79m |
Free float | 98.73m |
P/E (TTM) | -- |
Market cap | 65.51m CAD |
EPS (TTM) | -0.1718 CAD |
Data delayed at least 15 minutes, as of Jun 14 2024 14:35 BST.
More ▼